Entecavir (hepatitis B drug) leads to cross-resistance with HIV drugs
Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal, according to a new report in the New England Journal of Medicine.
Cross-resistance alarms raised earlier this year by Johns Hopkins researchers about a widely used antiviral therapy for hepatitis B liver infections have prompted swift treatment revisions by the drug??™s maker and governmental agencies.
Popularity: 4% [?]
Tags: Entecavir, hepatitis, leads, cross-resistance, drugs